A novel use for drotrecogin alfa (activated): successful treatment of septic shock associated with coccidioidomycosis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15578351.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We present 2 cases of septic shock associated with coccidioidomycosis that were successfully treated with drotrecogin alfa (activated) in combination with antifungal agents. The favorable outcomes, in light of the high mortality usually associated with this condition, suggest that drotrecogin alfa (activated) may be a valuable adjunct for treating septic shock due to endemic mycoses.
Medical subject headings
- Anti-Infective Agents
- Coccidioidomycosis
- Protein C
- Shock, Septic